KLK15 Antibodies

Santa Cruz Biotechnology provides a broad selection of KLK15 monoclonal antibodies for investigating KLK15 protein function and expression. KLK15 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLK15, also known as kallikrein-related peptidase 15, is a serine protease that plays a significant role in various physiological processes, including tissue remodeling and inflammation. Dysregulation of KLK15 has been implicated in several diseases, particularly in cancer development and progression. Research has shown that KLK15 expression levels can serve as potential diagnostic and prognostic markers in various cancers. Understanding KLK15 function and regulation is crucial for developing new therapeutic strategies. Investigating KLK15 expression patterns can reveal important insights into disease mechanisms and potential treatment approaches. KLK15 research continues to uncover new roles in both normal physiology and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KLK15 and its impact on human health.